Murphy J. Andrew's most recent trade in Edison International was a trade of 31,147 Non-qualified Stock Options (Right to Buy) done . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 31,147 | 31,147 | - | - | Non-qualified Stock Options (Right to Buy) | |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 4,441 | 4,441 | - | - | Restricted Stock Units | |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 8,846 | 30,831 (0%) | 0% | 0 | Common Stock | |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.61 per share. | 26 Feb 2025 | 3,244 | 27,587 (0%) | 0% | 52.6 | 170,667 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Sale or transfer of securities back to the company at price $ 60.00 per share. | 26 Feb 2025 | 1 | 27,586 (0%) | 0% | 60 | 60 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 3,153 | 0 | - | - | Restricted Stock Units | |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 3,153 | 23,002 (0%) | 0% | - | Common Stock | |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.01 per share. | 02 Jan 2025 | 1,017 | 21,985 (0%) | 0% | 80.0 | 81,370 | Common Stock |
| Regeneron Pharma | J Murphy Andrew | EVP Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 730.81 per share. | 16 Dec 2024 | 1,054 | 49,074 (0%) | 0% | 730.8 | 770,274 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 13,472 | 13,472 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 3,499 | 50,620 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 787.00 per share. | 06 Dec 2024 | 492 | 50,128 (0%) | 0% | 787 | 387,204 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Nov 2024 | 1,185 | 47,121 (0%) | 0% | 0 | Common Stock | |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Sale of securities on an exchange or to another person at price $ 85.45 per share. | 26 Aug 2024 | 23,896 | 19,849 (0%) | 0% | 85.4 | 2,041,856 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2024 | 23,896 | 0 | - | - | Non-qualified Stock Options (Right to Buy) | |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.38 per share. | 26 Aug 2024 | 23,896 | 43,745 (0%) | 0% | 79.4 | 1,896,864 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 1,362 | 23,896 | - | - | Non-qualified Stock Options (Right to Buy) | |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 23 Aug 2024 | 1,362 | 19,849 (0%) | 0% | 85 | 115,770 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.38 per share. | 23 Aug 2024 | 1,362 | 21,211 (0%) | 0% | 79.4 | 108,116 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 399.66 per share. | 13 Aug 2024 | 20,000 | 68,306 (0%) | 0% | 399.7 | 7,993,200 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 20,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1141.49 per share. | 13 Aug 2024 | 13,637 | 54,669 (0%) | 0% | 1141.5 | 15,566,499 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 1156.43 per share. | 13 Aug 2024 | 1,016 | 49,004 (0%) | 0% | 1156.4 | 1,174,933 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 1153.74 per share. | 13 Aug 2024 | 987 | 51,199 (0%) | 0% | 1153.7 | 1,138,741 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 1150.41 per share. | 13 Aug 2024 | 844 | 52,568 (0%) | 0% | 1150.4 | 970,946 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 1154.66 per share. | 13 Aug 2024 | 777 | 50,422 (0%) | 0% | 1154.7 | 897,171 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 1148.52 per share. | 13 Aug 2024 | 537 | 53,706 (0%) | 0% | 1148.5 | 616,755 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 1155.76 per share. | 13 Aug 2024 | 402 | 50,020 (0%) | 0% | 1155.8 | 464,616 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 1159.69 per share. | 13 Aug 2024 | 331 | 48,306 (0%) | 0% | 1159.7 | 383,857 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 1149.60 per share. | 13 Aug 2024 | 294 | 53,412 (0%) | 0% | 1149.6 | 337,982 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 1152.36 per share. | 13 Aug 2024 | 197 | 52,186 (0%) | 0% | 1152.4 | 227,015 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 1158.78 per share. | 13 Aug 2024 | 189 | 48,637 (0%) | 0% | 1158.8 | 219,009 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 1151.46 per share. | 13 Aug 2024 | 185 | 52,383 (0%) | 0% | 1151.5 | 213,020 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 1157.41 per share. | 13 Aug 2024 | 178 | 48,826 (0%) | 0% | 1157.4 | 206,019 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 1145.58 per share. | 13 Aug 2024 | 148 | 54,294 (0%) | 0% | 1145.6 | 169,546 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 1143.28 per share. | 13 Aug 2024 | 79 | 54,487 (0%) | 0% | 1143.3 | 90,319 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 1140.31 per share. | 13 Aug 2024 | 55 | 54,614 (0%) | 0% | 1140.3 | 62,717 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 1146.61 per share. | 13 Aug 2024 | 51 | 54,243 (0%) | 0% | 1146.6 | 58,477 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 1142.94 per share. | 13 Aug 2024 | 48 | 54,566 (0%) | 0% | 1142.9 | 54,861 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 1144.89 per share. | 13 Aug 2024 | 45 | 54,442 (0%) | 0% | 1144.9 | 51,520 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.01 per share. | 31 Jul 2024 | 32,505 | 52,164 (0%) | 0% | 69.0 | 2,243,170 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Sale of securities on an exchange or to another person at price $ 80.12 per share. | 31 Jul 2024 | 32,505 | 19,659 (0%) | 0% | 80.1 | 2,604,395 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2024 | 32,505 | 10,835 | - | - | Non-qualified Stock Options (Right to Buy) | |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.88 per share. | 26 Jul 2024 | 28,995 | 48,654 (0%) | 0% | 66.9 | 1,939,186 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jul 2024 | 28,995 | 0 | - | - | Non-qualified Stock Options (Right to Buy) | |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Sale of securities on an exchange or to another person at price $ 78.43 per share. | 26 Jul 2024 | 28,995 | 19,659 (0%) | 0% | 78.4 | 2,273,962 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Sale of securities on an exchange or to another person at price $ 75.14 per share. | 13 May 2024 | 45,012 | 19,659 (0%) | 0% | 75.1 | 3,382,274 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2024 | 22,228 | 0 | - | - | Non-qualified Stock Options (Right to Buy) | |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.50 per share. | 13 May 2024 | 22,228 | 62,631 (0%) | 0% | 62.5 | 1,389,250 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2024 | 20,744 | 0 | - | - | Non-qualified Stock Options (Right to Buy) | |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 60.78 per share. | 13 May 2024 | 20,744 | 40,403 (0%) | 0% | 60.8 | 1,260,820 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Sale of securities on an exchange or to another person at price $ 75.07 per share. | 13 May 2024 | 9,794 | 19,659 (0%) | 0% | 75.1 | 735,277 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 60.78 per share. | 13 May 2024 | 3,369 | 23,028 (0%) | 0% | 60.8 | 204,768 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2024 | 3,369 | 20,744 | - | - | Non-qualified Stock Options (Right to Buy) | |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2024 | 3,225 | 26,710 | - | - | Non-qualified Stock Options (Right to Buy) | |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.91 per share. | 13 May 2024 | 3,225 | 29,453 (0%) | 0% | 54.9 | 177,085 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2024 | 3,200 | 22,228 | - | - | Non-qualified Stock Options (Right to Buy) | |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.50 per share. | 13 May 2024 | 3,200 | 26,228 (0%) | 0% | 62.5 | 200,000 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2024 | 2,040 | 24,670 | - | - | Non-qualified Stock Options (Right to Buy) | |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.91 per share. | 13 May 2024 | 2,040 | 64,671 (0%) | 0% | 54.9 | 112,016 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Sale of securities on an exchange or to another person at price $ 75.01 per share. | 10 May 2024 | 58,099 | 19,659 (0%) | 0% | 75.0 | 4,358,244 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2024 | 19,408 | 29,935 | - | - | Non-qualified Stock Options (Right to Buy) | |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.91 per share. | 10 May 2024 | 19,408 | 77,758 (0%) | 0% | 54.9 | 1,065,693 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2024 | 19,358 | 25,428 | - | - | Non-qualified Stock Options (Right to Buy) | |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.50 per share. | 10 May 2024 | 19,358 | 58,350 (0%) | 0% | 62.5 | 1,209,875 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 60.78 per share. | 10 May 2024 | 19,333 | 38,992 (0%) | 0% | 60.8 | 1,175,060 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2024 | 19,333 | 24,113 | - | - | Non-qualified Stock Options (Right to Buy) | |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 399.66 per share. | 13 Mar 2024 | 20,000 | 68,306 (0%) | 0% | 399.7 | 7,993,200 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 971.82 per share. | 13 Mar 2024 | 14,217 | 54,089 (0%) | 0% | 971.8 | 13,816,365 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 956.34 per share. | 13 Mar 2024 | 1,108 | 50,364 (0%) | 0% | 956.3 | 1,059,625 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 954.66 per share. | 13 Mar 2024 | 870 | 52,017 (0%) | 0% | 954.7 | 830,554 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 957.35 per share. | 13 Mar 2024 | 730 | 49,634 (0%) | 0% | 957.4 | 698,866 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 953.77 per share. | 13 Mar 2024 | 576 | 52,887 (0%) | 0% | 953.8 | 549,372 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 955.54 per share. | 13 Mar 2024 | 545 | 51,472 (0%) | 0% | 955.5 | 520,769 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 959.36 per share. | 13 Mar 2024 | 512 | 48,645 (0%) | 0% | 959.4 | 491,192 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 958.34 per share. | 13 Mar 2024 | 477 | 49,157 (0%) | 0% | 958.3 | 457,128 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 952.40 per share. | 13 Mar 2024 | 444 | 53,463 (0%) | 0% | 952.4 | 422,866 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 968.20 per share. | 13 Mar 2024 | 196 | 48,306 (0%) | 0% | 968.2 | 189,767 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 951.92 per share. | 13 Mar 2024 | 182 | 53,907 (0%) | 0% | 951.9 | 173,249 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 965.51 per share. | 13 Mar 2024 | 78 | 48,519 (0%) | 0% | 965.5 | 75,310 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 961.74 per share. | 13 Mar 2024 | 47 | 48,598 (0%) | 0% | 961.7 | 45,202 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 966.29 per share. | 13 Mar 2024 | 17 | 48,502 (0%) | 0% | 966.3 | 16,427 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 963.00 per share. | 13 Mar 2024 | 1 | 48,597 (0%) | 0% | 963 | 963 | Common Stock |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 16,002 | 16,002 | - | - | Non-qualified Stock Options (Right to Buy) | |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 3,194 | 3,194 | - | - | Restricted Stock Units | |
| Edison International | J. Murphy Andrew | PRESIDENT & CEO, EDISON ENERGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 5,349 | 21,421 (0%) | 0% | 0 | Common Stock | |
| Edison International | Andrew J. Murphy | PRESIDENT & CEO, EDISON ENERGY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.95 per share. | 21 Feb 2024 | 1,978 | 19,443 (0%) | 0% | 67.9 | 134,405 | Common Stock |
| Edison International | Murphy Andrew J. | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2024 | 3,703 | 17,110 (0%) | 0% | - | Common Stock | |
| Edison International | Murphy J. Andrew | PRESIDENT & CEO, EDISON ENERGY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2024 | 3,703 | 0 | - | - | Restricted Stock Units | |
| Edison International | J. Andrew Murphy | PRESIDENT & CEO, EDISON ENERGY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.34 per share. | 02 Jan 2024 | 1,194 | 15,916 (0%) | 0% | 72.3 | 86,374 | Common Stock |
| Regeneron Pharma | Murphy Andrew J | EVP Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 856.71 per share. | 12 Dec 2023 | 7,657 | 48,306 (0%) | 0% | 856.7 | 6,559,828 | Common Stock |
| Regeneron Pharma | Murphy J Andrew | EVP Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 11,473 | 11,473 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 844.09 per share. | 08 Dec 2023 | 5,105 | 56,632 (0%) | 0% | 844.1 | 4,309,079 | Common Stock |
| Regeneron Pharma | Murphy J Andrew | EVP Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 3,199 | 61,737 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 843.79 per share. | 08 Dec 2023 | 883 | 58,538 (0%) | 0% | 843.8 | 745,067 | Common Stock |
| Regeneron Pharma | Murphy Andrew J | EVP Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 844.09 per share. | 08 Dec 2023 | 669 | 55,963 (0%) | 0% | 844.1 | 564,696 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2023 | 20,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | J Andrew Murphy | EVP Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 270.43 per share. | 04 Dec 2023 | 20,000 | 79,421 (0%) | 0% | 270.4 | 5,408,600 | Common Stock |
| Regeneron Pharma | J Andrew Murphy | EVP Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 813.58 per share. | 04 Dec 2023 | 13,464 | 65,957 (0%) | 0% | 813.6 | 10,954,041 | Common Stock |
| Regeneron Pharma | J Andrew Murphy | EVP Research | Sale of securities on an exchange or to another person at price $ 817.36 per share. | 04 Dec 2023 | 1,881 | 62,256 (0%) | 0% | 817.4 | 1,537,454 | Common Stock |